Halozyme Therapeutics, Inc. (HALO) stock saw a modest uptick, ending the day at $62.3 which represents a slight increase of $1.76 or 2.91% from the prior close of $60.54. The stock opened at $61.02 ...
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Steve Tipler as a managing director in the financial sponsors group. He will be based in the ...
As of August 26, 2024, the average one-year price target for Primerica is $278.72/share. The forecasts range from a low of $251.49 to a high of $315.00. The average price target represents an increase ...
Investors are facing the busiest quarterly rebalancing in about four years on Friday in a shake-up that could affect roughly $250 billion worth of stocks, according to a team of equity analysts at ...
Some results have been hidden because they may be inaccessible to you